TRIM21 and myositis disease: Myositis-associated autoantibodies are also present in PM/DM including anti-SSA and anti Ro-52 autoantibodies which are typically present in other autoimmune diseases providing a possible explanation to the increased risk of concomitant autoimmune/autoinflammatory diseases [7,8].